Streetbeat News

Price Targets

TSLA

Tesla Inc (NASDAQ:TSLA) has reduced the prices of its Model Y SUV in Canada by up to 6.9%, aligning its cost with that of the Model 3 sedan. The price cut affects the rear-wheel drive and long-range versions of the Model Y, with reductions of C$4000 (about $2,990). Despite this adjustment, the price of the Model Y Performance remains unchanged. This strategic pricing move comes as the Model Y achieved the status of the world's best-selling vehicle model in 2023, marking a significant milestone as the first EV to achieve this.

Portfolio Pulse from Anan Ashraf

February 02, 2024 | 8:56 am

QRVO

Analyst ratings for Qorvo (NASDAQ:QRVO) show a mix of opinions, with a recent shift towards a more positive outlook. The average 12-month price target has increased to $114.6, up 7.99% from the previous $106.12. Despite this, Qorvo faces challenges such as lower market capitalization, revenue decline of -4.71% as of September 30, 2023, below-average net margin, ROE, ROA, and a high debt-to-equity ratio. These factors suggest potential financial difficulties ahead.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:00 pm

T

Citigroup analyst Michael Rollins has maintained a Buy rating on AT&T (NYSE:T) and increased the price target from $19 to $20.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 8:57 pm

ROK

Citigroup analyst Andrew Kaplowitz has maintained a Buy rating on Rockwell Automation (NYSE:ROK) but lowered the price target from $351 to $330.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 8:55 pm

NAVI

Citigroup analyst Arren Cyganovich maintains a Neutral rating on Navient (NASDAQ:NAVI) and raises the price target from $17 to $18.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 8:52 pm

MTCH

Citigroup analyst Ygal Arounian has maintained a Neutral rating on Match Group (NASDAQ:MTCH) and increased the price target from $32 to $39.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 8:51 pm

BSX

Citigroup analyst Joanne Wuensch has maintained a Buy rating on Boston Scientific (NYSE:BSX) and increased the price target from $65 to $71.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 8:42 pm

APTV

Citigroup analyst Itay Michaeli maintains a Buy rating on Aptiv (NYSE:APTV) but lowers the price target from $150 to $136.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 8:39 pm

QRVO

Piper Sandler analyst Harsh Kumar maintains a Neutral rating on Qorvo (NASDAQ:QRVO) and lowers the price target from $120 to $105 as of 31 January 2024.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 8:27 pm

GABC

Piper Sandler analyst Nathan Race maintains a Neutral rating on German American Bancorp (NASDAQ:GABC) and raises the price target from $34 to $36 as of 31 January 2024.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 8:23 pm